PAHC · Nasdaq · CIK 0001069899

PHIBRO ANIMAL HEALTH CORP

PHIBRO ANIMAL HEALTH CORP’s most recent SEC filing in our snapshot is a Form SCHEDULE 13G/A filed on Oct 19, 2026. In fiscal 2026 (year ended Jun 30, 2026) it reported revenue of $1.5B and net income of $99.7M, according to its XBRL data on EDGAR. Its EDGAR record lists 48 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2026
$1.5B
Net income, FY2026
$99.7M
Form 4 filings on record, past 12 months
48

Company overview

Legal name (as filed)
PHIBRO ANIMAL HEALTH CORP
Ticker
PAHC
SEC Central Index Key (CIK)
0001069899
Industry (SIC)
Pharmaceutical Preparations (code 2834)
Business address
TEANECK, NJ
State or country of incorporation
DE
Fiscal year ends
June 30
SEC filer category
Large accelerated filer
Position in SEC ticker list
#2134 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from PHIBRO ANIMAL HEALTH CORP’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$942.3MFY2022$977.9MFY2023$1.0BFY2024$1.3BFY2025$1.5BFY2026
Net income
$49.2MFY2022$32.6MFY2023$2.4MFY2024$48.3MFY2025$99.7MFY2026
PAHC annual results
ItemFY2022
ended Jun 30, 2022		FY2023
ended Jun 30, 2023		FY2024
ended Jun 30, 2024		FY2025
ended Jun 30, 2025		FY2026
ended Jun 30, 2026
Revenue$942.3M$977.9M$1.0B$1.3B$1.5B
Net income$49.2M$32.6M$2.4M$48.3M$99.7M
Diluted EPS$1.21$0.81$0.06$1.19$2.43
Total assets$931.7M$971.4M$982.2M$1.4B$1.5B
Cash and equivalents$74.2M$41.3M$70.6M$68.0M$61.4M

XBRL tags used: revenue = RevenueFromContractWithCustomerExcludingAssessedTax; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

PAHC latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Aug 26, 202610-KAnnual report· period Jun 30, 2026Document · Index
May 6, 202610-QQuarterly report· period Mar 31, 2026Document · Index
Aug 26, 20268-KResults of operations· period Aug 26, 2026Document · Index
Sep 18, 2026DEF 14ADefinitive proxy statement· period Nov 3, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about PHIBRO ANIMAL HEALTH CORP, by form type:

4 ×17144 ×88-K ×4SCHEDULE 13G/A ×34/A ×2ARS ×1DEFA14A ×1DEF 14A ×110-K ×1SCHEDULE 13G ×1SCHEDULE 13D/A ×1
PAHC recent filings
FiledFormWhat it isOriginal
Oct 19, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Sep 18, 2026ARSARS· period Jun 30, 2026Document · Index
Sep 18, 2026DEFA14AAdditional proxy soliciting materialsDocument · Index
Sep 18, 2026DEF 14ADefinitive proxy statement· period Nov 3, 2026Document · Index
Sep 17, 20264/AStatement of changes in beneficial ownership (insider trade)· period Aug 6, 2026Document · Index
Sep 17, 20264/AStatement of changes in beneficial ownership (insider trade)· period Aug 6, 2026Document · Index
Sep 16, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 26, 20268-KResults of operations· period Aug 26, 2026Document · Index
Aug 26, 202610-KAnnual report· period Jun 30, 2026Document · Index
Aug 10, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 6, 2026Document · Index
Aug 10, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 6, 2026Document · Index
Aug 10, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 6, 2026Document · Index
Aug 10, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 6, 2026Document · Index
Aug 10, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 6, 2026Document · Index
Aug 10, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 6, 2026Document · Index
Aug 10, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 6, 2026Document · Index
Aug 10, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 6, 2026Document · Index
Aug 6, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 4, 2026Document · Index
Aug 6, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 4, 2026Document · Index
Aug 6, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 4, 2026Document · Index
Aug 6, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 4, 2026Document · Index
Aug 6, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 4, 2026Document · Index
Aug 6, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 4, 2026Document · Index
Aug 6, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Aug 4, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 4, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 4, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 4, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 4, 2026144Notice of proposed sale of securitiesDocument · Index
Aug 4, 2026144Notice of proposed sale of securitiesDocument · Index
Jul 30, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Jul 28, 20268-KOther events· period Jul 28, 2026Document · Index
Jul 2, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 1, 2026Document · Index
Jun 26, 20268-KDirector or officer change· period Jun 25, 2026Document · Index
Jun 16, 2026144Notice of proposed sale of securitiesDocument · Index
Jun 2, 20264Statement of changes in beneficial ownership (insider trade)· period May 29, 2026Document · Index
May 22, 2026SCHEDULE 13D/AActive beneficial ownership report (over 5%)Document · Index
May 14, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
May 7, 20264Statement of changes in beneficial ownership (insider trade)· period May 5, 2026Document · Index
May 6, 20268-KResults of operations· period May 6, 2026Document · Index

Insider filing activity

48 Form 4 filings appear in PHIBRO ANIMAL HEALTH CORP’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Pharmaceutical Preparations

All 194 companies in Pharmaceutical Preparations· Companies headquartered in New Jersey

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001069899 and XBRL company facts. PHIBRO ANIMAL HEALTH CORP on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.